Auszug
Jede Sauerstoffgabe, die länger als 15 h/Tag über mehr als 3 Monate indiziert ist, bezeichnet man als Langzeitsauerstofftherapie (»long term oxygen therapy«, LTOT).
Chapter PDF
Similar content being viewed by others
Literatur
Calverley PM, Walker P (2003) Chronic obstructive pulmonary disease. Lancet 362:1053–1061
Celli B, MacNee W (2004) Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23(6):932–946
Chailleux E, Fauroux B, Binet F, Dautzenberg B, Polu JM for the observatory group of ANTADIR (1996) Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical ventilation. Chest 109:741–749
Chambellan A, Chailleux E, Similowski T, ANTADIR Observatory group (2005) Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy. Chest 128(3):1201–1208
Croxton TL, Bailey WC for the NHLBI working group on long-term oxygen treatment in COPD (2006) Long term oxygen treatment in chronic obstructive pulmonary disease: recommendations for future research — an NHLBI workshop report. Am J Respir Crit Care Med 174:373–378
Eaton T, Garrett JE, Young P et al. (2002) Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study. Eur Respir J 20(2):306–312
Global Strategy for diagnosis, management and prevention of chronic obstructive pulmonary disease (2006) www.goldcopd.com
Gorecka D, Gorzelak K, Sliwinski P et al. (1997) Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. Thorax 52(8):674–679
Lacasse R, Lecours C, Pelletier R, Begin, Maltais F (2005) Randomised trial of ambulatory oxygen in oxygen-dependent COPD. Eur Respir J 25(6):1032–1038
Magnussen H et al. (2001) Leitlinien zur Langzeit-Sauerstofftherapie. Pneumologie 55:454–464
Machado MC, Krishnan JA, Buist SA et al. (2006) Sex differences in survival of oxygen-dependent patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 174(5):524–529
Martis S, Munos X, Rios J et al (2006) Body weight and comorbidity predict mortality in COPD patients treated with oxygen therapy. Eur Respir J 27(4):689–696
Medical Research Council Working Party (1981) Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1:681–686
Nocturnal Oxygen Therapy Trial Group (1980) Continuous or nocturnal oxygen therapy in hypoxaemic chronic obstructive lung disease. Ann Intern Med 93:391–398
Wijkstra PJ, Guyatt PH, Ambrosino N et al. (2001) International approaches to the prescription of long-term oxygen therapy. Eur Respir J 18(6):909–913
Literatur
Boe J, Dennis JH, O’Driscoll BR (2001) European Respiratory Task Force: European Society Guidelines on the use of nebulizers. Eur Resp J 18:228–242
Dhand R (2005) Inhalation therapy with metered-dose inhalers and dry powder inhalers in mechanically ventilated patients. Respir Care 50:1331–1334
Dolovich MB, MacIntyre NR, Anderson PJ et al. (2000) Consensus statement: Aerosols and delivery devices. J Aerosol Med 13:291–300
Everard ML, Devadason SG, LeSouef PN (1997) Flow early in the inspiratory manoeuvre affects the aerosol particle size distribution from a Turbuhaler. Respir Med 91:624–628
Haidl P, Schmidt F, Wiese C, Köhler D (2006) Peak inspiratory flow rate after methacholine challenge in asthmatic patients and its impact on the effect of formoterol via different inhalers. J Aerosol Med 19:364–371
Kohlhäufl M, Haidl P, Voshaar Th et al. (2004) Pulverinhalationssysteme. Dtsch Med Wochenschr 129:2048–2052
Köhler D, Fleischer W (2000) Theorie und Praxis der Inhalationstherapie. Arcis, München
Lenney J, Innes JA, Crompton GK (2000) Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. Respir Med 94:496–500
Matthys H (1998) Praxis der Aerosoltherapie. In: Scheuch G (Hrsg) Aerosole in der Aerosoltherapie II. Dustri, München
O’Riordan TG, Palmer LB, Smaldone GC (1994) Aerosol deposition in mechanically ventilated patients. Am J Respir Crit Care Med 149:214–219
Patton JS, Bukar JG, Eldon MA (2004) Clinical pharmacokinetics and pharmacodynamics of inhaled insulin. Clin Pharmacokinet 43:781–801
Pauwels R, Newman S, Borgstrom L (1997) Airway deposition and airway effects of anti-asthmatic drugs delivered from metered-dose inhalers Eur Respir J 10:2127–2138
Schuepp KG, Straub D, Moller A, Wildhaber JH (2004) Deposition of aerosols in infants and children 17:153–156
Voshaar Th (2005) Therapie mit Aerosolen. UNI-MED, Bremen
Voshaar Th, App EM, Berdel D et al. (2001) Empfehlungen für die Auswahl von Inhalationssystemen zur Medikamentenverabreichung. Pneumologie 55:579–586
Literaturverzeichnis
American Thoracic Society (2001) International Consensus Conferences in Intensive Care Medicine: noninvasive positive pressure ventilation in acute Respiratory failure. Am J Respir Crit Care Med 163:283–91
Anonymous (1999) Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation — a consensus conference report. Chest 116:521–34
Antonelli M, Conti G, Rocco M et al. (1998) A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure. N Engl J Med 339:429–35
Antonelli M, Conti G, Moro ML et al. (2001) Predictors of failure of noninvasive positive pressure ventilation in patients with acute hypoxemic respiratory failure: a multi-center study. Intensive Care Med 27:1718–28
Antonelli M, Conti G, Esquinas A et al. (2007) A multiple-center survey on the use in clinical practice of noninvasive ventilation as a first-line intervention for acute respiratory distress syndrome. Crit Care Med 35:18–25
Brochard L, Mancebo J, Wysocki M et al. (1995) Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 333:817–22
Brochard L (2003) Mechanical ventilation: invasive versus noninvasive. Eur Respir J Suppl 47:31s–37s
Brochard L, Mancebo J, Elliott MW (2002) Noninvasive ventilation for acute respiratory failure. Eur Respir J 19:712–21
Buyse B, Meersseman W, Demedts M (2003) Treatment of chronic respiratory failure in kyphoscoliosis: oxygen or ventilation? Eur Respir J 22:525–8
Casanova C, Celli BR, Tost L et al. (2000) Long-term controlled trial of nocturnal nasal positive pressure ventilation in patients with severe COPD. Chest 118:1582–90
Clini E, Sturani C, Rossi A et al. (2002) The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients. Eur Respir J 20:529–38
Conti G, Antonelli M, Navalesi P et al. (2002) Noninvasive vs. conventional mechanical ventilation in patients with chronic obstructive pulmonary disease after failure of medical treatment in the ward: a randomized trial. Intensive Care Med 28:1701–7
Diaz O, Begin P, Torrealba B, Jover E, Lisboa C (2002) Effects of noninvasive ventilation on lung hyperinflation in stable hypercapnic COPD. Eur Respir J 20:1490–8
Dreher M, Storre JH, Windisch W (2007) Noninvasive ventilation during walking in patients with severe COPD: a randomised cross-over trial. Eur Respir J 29:930–6
Elliott MW (2004) Non-invasive ventilation for acute respiratory disease. Br Med Bull 72:83–97
Esteban A, Frutos F, Tobin MJ et al. (1995) A comparison of four methods of weaning patients from mechanical ventilation. Spanish Lung Failure Collaborative Group. N Engl J Med 332:345–50
Esteban A, Frutos-Vivar F, Ferguson ND et al. (2004) Noninvasive positive-pressure ventilation for respiratory failure after extubation. N Engl J Med 350:2452–60
Ferrer M, Bernadich O, Nava S, Torres A. (2002) Noninvasive ventilation after intubation and mechanical ventilation. Eur Respir J 19:959–65
Ferrer M, Esquinas A, Arancibia F et al. (2003) Noninvasive ventilation during persistent weaning failure: a randomized controlled trial. Am J Respir Crit Care Med 168:70–6
Ferrer M, Valencia M, Nicolas JM, Bernadich O, Badia JR, Torres A (2006) Early noninvasive ventilation averts extubation failure in patients at risk: a randomized trial. Am J Respir Crit Care Med 173:164–70
Girault C, Daudenthun I, Chevron V, Tamion F, Leroy J, Bonmarchand G (1999) Noninvasive ventilation as a systematic extubation and weaning technique in acute-on-chronic respiratory failure: a prospective, randomized controlled study. Am J Respir Crit Care Med 160:86–92
Hilbert G, Gruson D, Vargas F et al. (2001) Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 344:481–7
Hill NS (2004) Noninvasive ventilation for chronic obstructive pulmonary disease. Respir Care 49:72–87; discussion 87–9
Janssens J, Derivaz S, Breitenstein E et al. (2003) Changing patterns in long-term noninvasive ventilation: a 7-year prospective study in the Geneva Lake area. Chest 123:67–79
Keenan SP, Sinuff T, Cook DJ, Hill NS (2004) Does noninvasive positive pressure ventilation improve outcome in acute hypoxemic respiratory failure? A systematic review. Crit Care Med 32:2516–23
Lightowler JV, Wedzicha JA, Elliott MW, Ram FSF (2003) Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis. BMJ 326:185
Lloyd-Owen SJ, Donaldson GC, Ambrosino N et al. (2005) Patterns of home mechanical ventilation use in Europe: results from the Eurovent survey. Eur Respir J 25:1025–31
Mehta S, Hill NS (2001) Noninvasive ventilation. Am J Respir Crit Care Med 163:540–77
Nava S, Ceriana P (2004) Causes of failure of noninvasive mechanical ventilation. Respir Care 49:295–303
Park M, Sangean MC, Volpe MdS et al. (2004) Randomized, prospective trial of oxygen, continuous positive airway pressure, and bilevel positive airway pressure by face mask in acute cardiogenic pulmonary edema. Crit Care Med 32:2407–15
Peter JV, Moran JL, Phillips-Hughes J, Graham P, Bersten AD (2006) Effect of non-invasive positive pressure ventilation (NIPPV) on mortality in patients with acute cardiogenic pulmonary oedema: a meta-analysis. Lancet 367:1155–63
Plant PK, Owen JL, Elliott MW (2000) Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial. Lancet 355:1931–5
Schönhofer B, Kohler D (2000) Effect of non-invasive mechanical ventilation on sleep and nocturnal ventilation in patients with chronic respiratory failure. Thorax 55:308–13
Schönhofer B, Sortor-Leger S (2002) Equipment needs for noninvasive mechanical ventilation. Eur Respir J 20:1029–36
Schönhofer B (2006). Nicht-invasive Beatmung — Grundlagen und moderene Praxis, 1. Aufl. UNI-MED, Bremen
Simonds AK, Elliott MW (1995) Outcome of domiciliary nasal intermittent positive pressure ventilation in restrictive and obstructive disorders. Thorax 50:604–9
Simonds AK (2003) Home ventilation. Eur Respir J Suppl 47:38s–46s
Storre JH, Seuthe B, Fiechter R et al. (2006) Average volume-assured pressure support in obesity hypoventilation: A randomized crossover trial. Chest 130:815–21
Wijkstra PJ, Lacasse Y, Guyatt GH et al. (2003) A meta-analysis of nocturnal noninvasive positive pressure ventilation in patients with stable COPD. Chest 124:337–43
Winck JC, Azevedo LF, Costa-Pereira A, Antonelli M, Wyatt JC (2006) Efficacy and safety of non-invasive ventilation in the treatment of acute cardiogenic pulmonary edema — a systematic review and meta-analysis. Crit Care 10:R69
Windisch W, Kostic S, Dreher M, Virchow JCJ, Sorichter S (2005) Outcome of patients with stable COPD receiving controlled noninvasive positive pressure ventilation aimed at a maximal reduction of Pa(CO2). Chest 128:657–62
Windisch W, Dreher M, Storre JH, Sorichter S (2006) Nocturnal noninvasive positive pressure ventilation: Physiological effects on spontaneous breathing. Respir Physiol Neurobiol 150:251–60
Literatur
Amato MB, Barbas CS, Medeiros DM et al. (1998) Effect of a protectiveventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 338(6):347–354
Ashbaugh DG, Bigelow DB, Petty TL, Levine BE (1967) Acute respiratory distress in adults. Lancet 2(7511):319–323
Bein T, Weber F, Philipp A et al. (2006) A new pumpless extracorporeal interventional lung assist in critical hypoxemia/hypercapnia. Crit Care Med 34(5):1372–1377
Borges JB, Okamoto VN, Matos GFJ et al. (2006) Reversibility of lung collapse and hypoxemia in early acute respiratory distress syndrome. Am J Respir Crit Care Med 174:268–278
Brochard L, Rauss A, Benito S et al. (1994) Comparison of three methods of gradual withdrawal from ventilatory support during weaning from mechanical ventilation. Am J Respir Crit Care Med 150:896–903
Brower RG, Lanken PN, MacIntyre N et al. (2004) Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 351(4):327–336
deJonge E, Schultz MJ, Spanjaard L, Bossuyt PMM, Vroom MB, Dankert J, Kesecioglu J (2003) Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomized controlled trial. Lancet 362:1011–1016
Ely EW, Baker AM, Dunagan DP et al. (1996) Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. NEJM 335:1864–1869
Fischer S, Simon AR, Welte T, Hoeper MM, Meyer A, Tessmann R, Gorbandt B, Gottlieb J, Haverich A, Strueber M (2006) Bridge to lung transplantation with the novel pumpless interventional assist NovaLung. J Thorac Cardiovasc Surg 131:719–23
Gattinoni L, Agostoni A, Pesenti A et al. (1980) Treatment of acute respiratory failure with low-frequency positive-pressure ventilation and extracorporeal removal of CO2. Lancet 2(8189):292–294
Gattinoni L, Tognoni G, Pesenti A et al. (2001) Effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med 345:568–573
Gattinoni L, Vagginelli F, Carlesco E, Taccone P, Conte V, Chiumello D, Valenza F, Caironi P, Pesenti A (2003) Decrease in paCO2 with prone position is predictive of improved outcome in acute respiratory distress syndrome. Crit Care Med 31:2727–2733
Griffiths MJD, Evans TW (2005) Inhaled nitric oxide therapy in adults. N Engl J Med 353:2683–2695
Hager DN, Krishnan JA, Hayden DL, Brower RG (2005) Tidal volume reduction in patients with acute lung injury when plateau pressures are not high. Am J Respir Crit Care Med 172:1241–1245
Hill JD, O’Brien TG, Murray JJ et al. (1972) Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shocklung syndrome). Use of the Bramson membrane lung. N Engl J Med 286(12):629–634
Koeman M, van der Ven AJAM, Hak E et al. (2006) Oral decontamination with Chlorhexidin reduces the incidence of Ventilator-associated pneumonia. Am J Respir Crit Care Med 173:1348–1355
Kress, JP, Pohlmann AE, O’Connor MF, Hall JB (2000) Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 342:1471–1477
Lellouche F, Mancebo J, Jolliet P et al. (2006) A multicenter randomized trial of computer-driven protocolized weaning from mechanical ventilation. Am J Resp Crit Care Med 174:894–900
MacIntyre NR, Cheng K-CG, McConnell R (1997) Applied PEEP during pressure support reduces the inspiratory threshold load of intrinsic PEEP. Chest 111:188–193
MacIntyre NR, Cook DJ, Guyatt GH (2001) Evidence based guidelines for weaning and discontinuing ventilatory support. American College of Chest Physicians, American Association for Respiratory Care, and American College of Critical Care Medicine. Chest 120(6 Suppl):375S–484S
Mancebo J, Fernández R, Blanch L et al. (2005) A multicenter trial of prolonged prone ventilation in severe acute respiratory distress syndrome. Am J Respir Crit Care Med 173:1233–1239
Morán I, Zavala E, Fernandez R, Blanch L, Mancebo J (2003) Recruitment manoeuvres in acute lung injury/acute respiratory distress syndrome. Eur Respir J 22:Suppl.42,37s–42s
Morris AH, Wallace CJ, Menlove RL et al. (1994) Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med 149(2 Pt 1):295–305
Rumbak MJ, Newton M, Truncale T, Schwartz SW, Adams JW, Hazard PB (2004) A prospective, randomized study comparing early percutaneous dilational trecheotomy to prolonged transleryngeal intubation (delayed tracheotomy) in critically ill medical patients. Crit Care Med 32:1689–1694
The Acute Respiratory Distress Syndrome Network (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301–1308
The National Heart, Lung and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical trials Network (2004) Higher versus lower positive end expiratoy pressures in patients with the acute respiratory distress syndrome. N Engl J Med 351:327–336
The National Heart, Lung and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical trials Network (2006) Efficiacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 354:1671–1684
The National Heart, Lung and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical trials Network (2006) Pulmonaryartery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med 354:2213–2224
The National Heart, Lung and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical trials Network (2006) Comparision of Two Fluid-Management Strategies in Acute Lung Injury. N Engl J Med 354:2564–2575
Spragg RG, Lewis JF, Walmrath HD et al. (2004) Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. N Engl J Med 351:884–892
Zapol WM, Snider MT, Hill JD et al. (1979) Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. Jama 242(20):2193–2196
Literatur
Toronto Lung Transplant Group (1986) Unilateral lung transplantation for pulmonary fibrosis. N Engl J Med 314:1140–5
The American Society for Transplant Physicians (ASTP)/ American Thoracic Society (ATS)/ European Respiratory Society (ERS)/ International Society for Heart and Lung Transplantation (ISHLT) (1998) International guidelines for the selection of lung transplant candidates. Am J Respir Crit Care Med 158:335–9
Adami J, Gabel H, Lindelof B, Ekstrom K, Rydh B, Glimelius B, Ekbom A, Adami HO, Granath F (2003) Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 89:1221–7
Aigner C, Winkler G, Jaksch P, Seebacher G, Lang G, Taghavi S, Wisser W, Klepetko W (2005) Extended donor criteria for lung transplantation — a clinical reality. Eur J Cardiothorac Surg 27:757–61
Amital A, Shitrit D, Raviv Y, Bendayan D, Sahar G, Bakal I, Kramer MR (2006) Development of malignancy following lung transplantation. Transplantation 81:547–51
Anthonisen NR (1989) Prognosis in chronic obstructive pulmonary disease: results from multicenter clinical trials. Am Rev Respir Dis 140:S95–9
Aris RM, Gilligan PH, Neuringer IP, Gott KK, Rea J, Yankaskas JR (1997) The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome. Am J Respir Crit Care Med 155:1699–704
Armitage JM, Kurland G, Michaels M, Cipriani LA, Griffith BP, Fricker FJ (1995) Critical issues in pediatric lung transplantation. J Thorac Cardiovasc Surg 109:60–4; discussion 64–5
Bando K, Armitage JM, Paradis IL et al. (1994) Indications for and results of single, bilateral, and heart-lung transplantation for pulmonary hypertension. J Thorac Cardiovasc Surg 108:1056–65
Bando K, Paradis IL, Keenan RJ et al. (1995) Comparison of outcomes after single and bilateral lung transplantation for obstructive lung disease. J Heart Lung Transplant 14:692–8
Bando K, Paradis IL, Similo S et al. (1995) Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management. J Thorac Cardiovasc Surg 110:4–13; discussion 13–4
Barst RJ, Rubin LJ, McGoon MD, Caldwell EJ, Long WA, Levy PS (1994) Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin. Ann Intern Med 121:409–15
Barten MJ, Rahmel A, Garbade J, Bold A, Bittner HB, Dhein S, Mohr FW, Gummert JF (2005) Pharmacodynamic monitoring of the conversion of cyclosporine to tacrolimus in heart and lung transplant recipients. Transplant Proc 37:4532–4
Bartz RR, Love RB, Leverson GE, Will LR, Welter DL, Meyer KC (2003) Pre-transplant mechanical ventilation and outcome in patients with cystic fibrosis. J Heart Lung Transplant 22:433–8
Bavaria JE, Pochettino A, Kotloff RM, Rosengard BR, Wahl PM, Roberts JR, Palevsky HI, Kaiser LR (1998) Effect of volume reduction on lung transplant timing and selection for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg 115:9–17; discussion 17–8
Baz MA, Palmer SM, Staples ED, Greer DG, Tapson VF, Davis DD (2001) Lung transplantation after long-term mechanical ventilation: results and 1-year follow-up. Chest 119:224–7
Bhorade SM, Vigneswaran W, McCabe MA, Garrity ER (2000) Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation. J Heart Lung Transplant 19:1199–204
Burke CM, Theodore J, Dawkins KD et al. (1984) Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation. Chest 86:824–9
Caforio AL, Fortina AB, Piaserico S et al. (2000) Skin cancer in heart transplant recipients: risk factor analysis and relevance of immunosuppressive therapy. Circulation 102:III222–7
Chacon RA, Corris PA, Dark JH, Gibson GJ (2000) Tests of airway function in detecting and monitoring treatment of obliterative transplantation in selected patients with coronary artery disease. J Thorac Cardiovasc Surg 124:1250–1
Connors AF Jr, Dawson NV, Thomas C et al. (1996) Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 154:959–67
Cooper JD, Pearson FG, Patterson GA, Todd TR, Ginsberg RJ, Goldberg M, Waters P (1989) Use of silicone stents in the management of airway problems. Ann Thorac Surg 47:371–8
Cooper JD, Billingham M, Egan T et al. (1993) A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant 12:713–6
Cooper JD, Patterson GA, Trulock EP (1994) Results of single and bilateral lung transplantation in 131 consecutive recipients. Washington University Lung Transplant Group. J Thorac Cardiovasc Surg 107:460–70; discussion 470-1
Cooper JD, Patterson GA, Sundaresan RS, Trulock EP, Yusen RD, Pohl MS, Lefrak SS (1996) Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. J Thorac Cardiovasc Surg 112:1319–29; discussion 1329-30
Dahlman S, Jeppsson A, Schersten H, Nilsson F (2006) Expanding the donor pool: lung transplantation with donors 55 years and older. Transplant Proc 38:2691–3
D’Alonzo GE, Barst RJ, Ayres SM et al. (1991) Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 115:343–9
Davies HR, Richeldi L, Walters EH (2003) Immunomodulatory agents for idiopathic pulmonary fibrosis. Cochrane Database Syst Rev: CD003134
De Hoyos A, Maurer JR (1992) Complications following lung transplantation. Semin Thorac Cardiovasc Surg 4:132–46
de Hoyos AL, Patterson GA, Maurer JR, Ramirez JC, Miller JD, Winton TL (1992) Pulmonary transplantation. Early and late results. The Toronto Lung Transplant Group. J Thorac Cardiovasc Surg 103:295–306
De Meester J, Smits JM, Persijn GG, Haverich A (1999) Lung transplant waiting list: differential outcome of type of end-stage lung disease, one year after registration. J Heart Lung Transplant 18:563–71
Detterbeck FC, Egan TM, Mill MR (1995) Lung transplantation after previous thoracic surgical procedures. Ann Thorac Surg 60:139–43
Dobbin C, Maley M, Harkness J, Benn R, Malouf M, Glanville A, Bye P (2004) The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosis: results from a single large referral centre. J Hosp Infect 56:277–82
Doershuk CF, Stern RC (1999) Timing of referral for lung transplantation for cystic fibrosis: overemphasis on FEV1 may adversely affect overall survival. Chest 115:782–7
Duncan SR, Grgurich WF, Iacono AT et al. (1994) A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation. Am J Respir Crit Care Med 150:146–52
Dusmet M, Winton TL, Kesten S, Maurer J (1996) Previous intrapleural procedures do not adversely affect lung transplantation. J Heart Lung Transplant 15:249–54
Estenne M, Maurer JR, Boehler A, Egan JJ, Frost A, Hertz M, Mallory GB, Snell GI, Yousem S (2002) Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 21:297–310
Fein AM, Branman SS, Casaburi R, Irvin CG, Make BJ, Rodarte JR, Solway J (1996) Lung volume reduction surgery. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, May 1996. Am J Respir Crit Care Med 154:1151–2
Gammie JS, Keenan RJ, Pham SM, McGrath MF, Hattler BG, Khoshbin E, Griffith BP (1998) Single-versus double-lung transplantation for pulmonary hypertension. J Thorac Cardiovasc Surg 115:397–402; discussion 402-3
Garrity ER Jr, Mehra MR (2004) An update on clinical outcomes in heart and lung transplantation. Transplantation 77:S68–74
Ghofrani HA, Wiedemann R, Rose F et al. (2002) Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial. Lancet 360:895–900
Groetzner J, Wittwer T, Kaczmarek I et al. (2006) Conversion to sirolimus and mycophenolate can attenuate the progression of bronchiolitis obliterans syndrome and improves renal function after lung transplantation. Transplantation 81:355–60
Hamm H (1995) Physiology, pathophysiology and clinical aspects of the pleural cavity. Revision of traditional models. Fortschr Med 113:283–4
Hanson D, Winterbauer RH, Kirtland SH, Wu R (1995) Changes in pulmonary function test results after 1 year of therapy as predictors of survival in patients with idiopathic pulmonary fibrosis. Chest 108:305–10
Haverich A, Aziz S, Scott WC, Jamieson SW, Shumway NE (1986) Improved lung preservation using Euro-Collins solution for flushperfusion. Thorac Cardiovasc Surg 34:368–76
Hoeper MM, Faulenbach C, Golpon H, Winkler J, Welte T, Niedermeyer J (2004) Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertension. Eur Respir J 24:1007–10
Ikonen T, Kivisaari L, Harjula AL et al. (1996) Value of high-resolution computed tomography in routine evaluation of lung transplantation recipients during development of bronchiolitis obliterans syndrome. J Heart Lung Transplant 15:587–95
Jamieson SW, Kapelanski DP, Sakakibara N et al. (2003) Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg 76:1457–62; discussion 1462-4
Jaramillo A, Smith MA, Phelan D et al. (1999) Temporal relationship between the development of anti-HLA antibodies and the development of bronchiolitis obliterans syndrome after lung transplantation. Transplant Proc 31:185–6
Joyal D, Cantarovich M, Cecere R, Giannetti N (2004) Early experience with two-dose daclizumab in the prevention of acute rejection in cardiac transplantation. Clin Transplant 18:493–6
Keenan RJ, Lega ME, Dummer JS et al. (1991) Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation. Transplantation 51:433–8
Kerem E, Reisman J, Corey M, Canny GJ, Levison H (1992) Prediction of mortality in patients with cystic fibrosis. N Engl J Med 326:1187–91
Keshavjee SH, Yamazaki F, Yokomise H, Cardoso PF, Mullen JB, Slutsky AS, Patterson GA (1992) The role of dextran 40 and potassium in extended hypothermic lung preservation for transplantation. J Thorac Cardiovasc Surg 103:314–25
Khaghani A, Banner N, Ozdogan E et al. (1991) Medium-term results of combined heart and lung transplantation for emphysema. J Heart Lung Transplant 10:15–21
Klepetko W, Mayer E, Sandoval J et al. (2004) Interventional and surgical modalities of treatment for pulmonary arterial hypertension. J Am Coll Cardiol 43:73S–80S
Kotloff RM, Zuckerman JB (1996) Lung transplantation for cystic fibrosis: special considerations. Chest 109:787–98
Lee R, Meyers BF, Sundt TM, Trulock EP, Patterson GA (2002) Concomitant coronary artery revascularization to allow successful lung transplantation in selected patients with coronary artery disease. J Thorac Cardiovasc Surg 124:1250–1
Levine SM, Jenkinson SG, Bryan CL, Anzueto A, Zamora CA, Gibbons WJ, Calhoon JH, Trinkle JK (1992) Ventilation-perfusion inequalities during graft rejection in patients undergoing single lung transplantation for primary pulmonary hypertension. Chest 101:401–5
Levine SM, Anzueto A, Peters JI, Calhoon JH, Jenkinson SG, Bryan CL (1994) Single lung transplantation in patients with systemic disease. Chest 105:837–41
Levy RD, Ernst P, Levine SM et al. (1993) Exercise performance after lung transplantation. J Heart Lung Transplant 12:27–33
Lipson DA, Palevsky HI, Kotloff RM, Edelman J (1998) Conversion to tacrolimus (FK506) from cyclosporine after orthotopic lung transplantation. Transplant Proc 30:1505–7
Martinez JA, Paradis IL, Dauber JH et al. (1997) Spirometry values in stable lung transplant recipients. Am J Respir Crit Care Med 155:285–90
McKenna RJ, Jr., Brenner M, Fischel RJ, Gelb AF (1996) Should lung volume reduction for emphysema be unilateral or bilateral? J Thorac Cardiovasc Surg 112:1331–8; discussion 1338-9
Mendeloff EN, Meyers BF, Sundt TM et al. (2002) Lung transplantation for pulmonary vascular disease. Ann Thorac Surg 73:209–17; discussion 217-9
Meyer DM, Bennett LE, Novick RJ, Hosenpud JD (2001) Single vs bilateral, sequential lung transplantation for end-stage emphysema: influence of recipient age on survival and secondary end-points. J Heart Lung Transplant 20:935–41
Meyer DM, Edwards LB, Torres F, Jessen ME, Novick RJ (2005) Impact of recipient age and procedure type on survival after lung transplantation for pulmonary fibrosis. Ann Thorac Surg 79:950–7; discussion 957-8
Meyers BF, Lynch JP, Battafarano RJ, Guthrie TJ, Trulock EP, Cooper JD, Patterson GA (2000) Lung transplantation is warranted for stable, ventilator-dependent recipients. Ann Thorac Surg 70:1675–8
Morrish WF, Herman SJ, Weisbrod GL, Chamberlain DW (1991) Bronchiolitis obliterans after lung transplantation: findings at chest radiography and high-resolution CT. The Toronto Lung Transplant Group. Radiology 179:487–90
Neumayer HH (2005) Introducing everolimus (Certican) in organ transplantation: an overview of preclinical and early clinical developments. Transplantation 79:S72–5
Niedermeyer J, Bewig B, Bickhardt T et al. (2001) Lung and heartlung transplantation. Guidelines for indications and preoperative diagnosis. Pneumologie 55:396–400
Novick RJ, Andreassian B, Schafers HJ et al. (1994) Pulmonary retransplantation for obliterative bronchiolitis. Intermediate-term results of a North American-European series. J Thorac Cardiovasc Surg 107:755–63
Olschewski H, Simonneau G, Galie N et al. (2002) Inhaled iloprost for severe pulmonary hypertension. N Engl J Med 347:322–9
Orens JB, Estenne M, Arcasoy S et al. (2006) International guidelines for the selection of lung transplant candidates: 2006 update — a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 25:745–55
Palmer SM, Miralles AP, Lawrence CM, Gaynor JW, Davis RD, Tapson VF (1999) Rabbit antithymocyte globulin decreases acute rejection after lung transplantation: results of a randomized, prospective study. Chest 116:127–33
Pasque MK, Cooper JD, Kaiser LR, Haydock DA, Triantafillou A, Trulock EP (1990) Improved technique for bilateral lung transplantation: rationale and initial clinical experience. Ann Thorac Surg 49:785–91
Patterson GA, Cooper JD, Goldman B et al. (1988) Technique of successful clinical double-lung transplantation. Ann Thorac Surg 45:626–33
Patterson GM, Wilson S, Whang JL, Harvey J, Agacki K, Patel H, Theodore J (1996) Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: a comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second. J Heart Lung Transplant 15:175–81
Penn I (1990) Cancers complicating organ transplantation. N Engl J Med 323:1767–9
Penn I (1993) Incidence and treatment of neoplasia after transplantation. J Heart Lung Transplant 12:S328–36
Pham SM, Qi XS, Mallon SM et al. (2002) Sirolimus and tacrolimus in clinical cardiac transplantation. Transplant Proc 34:1839–42
Pochettino A, Kotloff RM, Rosengard BR, Arcasoy SM, Blumenthal NP, Kaiser LR, Bavaria JE (2000) Bilateral versus single lung transplantation for chronic obstructive pulmonary disease: intermediate-term results. Ann Thorac Surg 70:1813–8; discussion 1818-9
Puskas JD, Hirai T, Christie N, Mayer E, Slutsky AS, Patterson GA (1992) Reliable thirty-hour lung preservation by donor lung hyperinflation. J Thorac Cardiovasc Surg 104:1075–83
Quantz MA, Bennett LE, Meyer DM, Novick RJ (2000) Does human leukocyte antigen matching influence the outcome of lung transplantation? An analysis of 3,549 lung transplantations. J Heart Lung Transplant 19:473–9
Reams BD, McAdams HP, Howell DN, Steele MP, Davis RD, Palmer SM (2003) Posttransplant lymphoproliferative disorder: incidence, presentation, and response to treatment in lung transplant recipients. Chest 124:1242–9
Reichenspurner H (2005) Overview of tacrolimus-based immunosuppression after heart or lung transplantation. J Heart Lung Transplant 24:119–30
Reitz BA, Wallwork JL, Hunt SA, Pennock JL, Billingham ME, Oyer PE, Stinson EB, Shumway NE (1982) Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med 306:557–64
Revell MP, Lewis ME, Llewellyn-Jones CG, Wilson IC, Bonser RS (2000) Conservation of small-airway function by tacrolimus/cyclosporine conversion in the management of bronchiolitis obliterans following lung transplantation. J Heart Lung Transplant 19:1219–23
Reynaud-Gaubert M, Thomas P, Badier M, Cau P, Giudicelli R, Fuentes P (2000) Early detection of airway involvement in obliterative bronchiolitis after lung transplantation. Functional and bronchoalveolar lavage cell findings. Am J Respir Crit Care Med 161:1924–9
Rubin LJ, Badesch DB, Barst RJ et al. (2002) Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 346:896–903
Saiman L, Mehar F, Niu WW, Neu HC, Shaw KJ, Miller G, Prince A (1996) Antibiotic susceptibility of multiply resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis, including candidates for transplantation. Clin Infect Dis 23:532–7
Schafers HJ, Haydock DA, Cooper JD (1991) The prevalence and management of bronchial anastomotic complications in lung transplantation. J Thorac Cardiovasc Surg 101:1044–52
Schwartz DA, Van Fossen DS, Davis CS, Helmers RA, Dayton CS, Burmeister LF, Hunninghake GW (1994) Determinants of progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 149:444–9
Seersholm N, Kok-Jensen A, Dirksen A (1994) Survival of patients with severe alpha 1-antitrypsin deficiency with special reference to non-index cases. Thorax 49:695–8
Seoane L, Arcement LM, Valentine VG, McFadden PM (2005) Long-term survival in lung transplant recipients after successful preoperative coronary revascularization. J Thorac Cardiovasc Surg 130:538–41
Sharples LD, Tamm M, McNeil K, Higenbottam TW, Stewart S, Wallwork J (1996) Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation — early risk factors. Transplantation 61:560–6
Smith CM (1997) Patient selection, evaluation, and preoperative management for lung transplant candidates. Clin Chest Med 18:183–97
Smith MA, Sundaresan S, Mohanakumar T et al. (1998) Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome. J Thorac Cardiovasc Surg 116:812–20
Snell GI, de Hoyos A, Krajden M, Winton T, Maurer JR (1993) Pseudomonas cepacia in lung transplant recipients with cystic fibrosis. Chest 103:466–71
Snell GI, Richardson M, Griffiths AP, Williams TJ, Esmore DS (1999) Coronary artery disease in potential lung transplant recipients > 50 years old: the role of coronary intervention. Chest 116:874–9
Snell GI, Levvey BJ, Zheng L, Bailey M, Orsida B, Law L, Whitford HM, Kotsimbos TC, Williams TJ (2005) Everolimus alters the bronchoalveolar lavage and endobronchial biopsy immunologic profile post-human lung transplantation. Am J Transplant 5:1446–51
Soghikian MV, Valentine VG, Berry GJ, Patel HR, Robbins RC, Theodore J (1996) Impact of ganciclovir prophylaxis on heart-lung and lung transplant recipients. J Heart Lung Transplant 15:881–7
Speich R, Thurnheer R, Gaspert A, Weder W, Boehler A (1999) Efficacy and cost effectiveness of oral ganciclovir in the prevention of cytomegalovirus disease after lung transplantation. Transplantation 67:315–20
Spray TL, Mallory GB, Canter CE, Huddleston CB, Kaiser LR (1992) Pediatric lung transplantation for pulmonary hypertension and congenital heart disease. Ann Thorac Surg 54:216–23; discussion 224-5
Thabut G, Mal H, Castier Y, Groussard O, Brugiere O, Marrash-Chahla R, Leseche G, Fournier M (2003) Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis. J Thorac Cardiovasc Surg 126:469–75
Treede H, Klepetko W, Reichenspurner H, Zuckermann A, Meiser B, Birsan T, Wisser W, Reichert B (2001) Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocols. J Heart Lung Transplant 20:511–7
Trulock EP (1993) Management of lung transplant rejection. Chest 103:1566–76
Trulock EP, Edwards LB, Taylor DO, Boucek MM, Keck BM, Hertz MI (2006) Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult lung and heart-lung transplantation report 2006. J Heart Lung Transplant 25:880–92
Waddell TK, Bennett L, Kennedy R, Todd TR, Keshavjee SH (2002) Heart-lung or lung transplantation for Eisenmenger syndrome. J Heart Lung Transplant 21:731–7
Walter N, Collard HR, King TE Jr (2006) Current perspectives on the treatment of idiopathic pulmonary fibrosis. Proc Am Thorac Soc 3:330–8
Weill D, Torres F, Hodges TN, Olmos JJ, Zamora MR (1999) Acute native lung hyperinflation is not associated with poor outcomes after single lung transplant for emphysema. J Heart Lung Transplant 18:1080–7
Yankaskas JR, Mallory GB Jr (1998) Lung transplantation in cystic fibrosis: consensus conference statement. Chest 113:217–26
Yonan NA, el-Gamel A, Egan J, Kakadellis J, Rahman A, Deiraniya AK (1998) Single lung transplantation for emphysema: predictors for native lung hyperinflation. J Heart Lung Transplant 17:192–201
Literatur
Beamis JF, Mathur PN, Mehta A (Hrsg.) (2004) Interventional Pulmonary Medicine. Dekker, New York
Bolliger CT, Mathur PN (Hrsg.) (2000) Interventional Bronchoscopy. Karger, Basel
Bolliger CT, Sutedja TG, Strausz J, Freitag L (2006) Therapeutic bronchoscopy with immediate effect: laser, electrocautery, argon plasma coagulation and stents. Europ Respir J 27(6):1258–71
Deutsche Gesellschaft für Pneumologie (1998) Empfehlungen zur bronchoskopischen Behandlung tracheobronchialer Verschlüsse, Stenosen und muraler maligner Tumoren. Pneumologie 52:243–248
Dobbertin I, Dierkesmann R (Hrsg.) (2004) Lehrbuch und Atlas der Bronchoskopie. Huber, Bern
Freitag L, Macha HN, Loddenkemper R (2001) Interventional bronchoscopic procedures. In: Spiro SG (ed.) Lung Cancer. European Respiratory Monograph 6(17):272–304
Freitag L, Macha NH (2004) Hämoptysen. Internist 45(5):555–64
Freitag L (2006) Bronchoskopie auf der Intensivstation. In: Zerkowski HR, Baumann G (Hrsg.) Herzakutmedizin. Steinkopff, Darmstadt, 2006
Kollofrath O (1897 ) Entfernung eines Knochenstücks aus dem rechten Bronchus auf natürlichem Wege und unter Anwendung der directen Laryngoscopie. MMW 38:1038–1039
Prakash UBS (Hrsg.) (1994) Bronchoscopy. Raven Press, New York
Rodriguez-Panadero F, Janssen JP, Astoul P (2006) Thoracoscopy: general overview and place in the diagnosis and management of pleural effusion. Eur Respi J 28:409–421
Literatur
ATS (1994) Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 149:1359–1374
Demers C, Grissberg JS (1992) Deep venous thrombosis and pulmonary embolism in pregnancy. Clin Chest Med 13:645–656
Hanania NA, Cazzola M (2006) Acute espiratory failure in Pregnancy. In: Narva S, Welte T (eds.) Respiratory emergencies. Eur Respir Mon 36:241–258
King TE Jr (1992) Restrictive lung disease in pregnancy. Clin Chest Med 13:607–622
Koboloff RM, Fitz Simmons SC, Fiel SB (1992) Fertility and pregnancy in patients with cystic fibrosis. Clin Chest Med 13:607–622
Laube DI, Poceta JS, Morales MC, Peacocr MD, Mitler MM (1996) Self reported snoring in pregnancy. Association with fetal outcome. Chest 109:885–889
Mapp C, Buist S (eds.) (2003) Respiratory diseases in women. Eur Respir Mon 25
Minerbi-Codish I, Fraser D, Avnun L, Glezerman M, Heimer D (1998) Influence of Asthma in Pregnancy on Labor and the Newborn. Respiration 65:130–135
Neumann SM, Freyschmidt J, Holland BR, Henschel M, Gahnem NR (1997) Vergleich der Perfusions-Ventilations-Szintigraphie mit dem Spiral-CT bei akuter Lungenembolie. Med Klin 92:635–641
Olesen C, Thrane N, Soerensen HAT, Olsen J (2001) A population-based study of asthma drugs during pregnancy: changing the intensity of asthma therapy and perinatal outcomes. Respiration 68:256–261
Jeldio SM (1992) Dyspnoea during pregnancy distinguising cardiac from pulmonary causes. Clin Chest Med 13:567–585
Rigk N, Kalassian KG, Gilligan T, Drazin MI, Daniel DL (1996) Obstetric complications in pulmonary and critical care medicine. Chest 110:791–809
Rodriguez I, Niedermann MS (1992) Pneumonie complicating pregnancy. Clin Chest Med 13:679–691
Semedstad KG, Cramb R, Morrison DH (1994) Pulmonary hypertension and pregnancy, a series of 8 cases. Can J Anaesth 41:502–512
Stenius-Arniala B, Pürila P, Teramo K (1988) Asthma and pregnancy a prospective study of 198 pregnancies. Thorax 43:12–18
Wurm K (Hrsg) (1997) Sarkoidose. Thieme, Stuttgart
Literatur
Batra A, Schütz CG, Lindinger P (2006) Tabakabhängigkeit. In: Schmidt LG, Gaspar M, Falkai P, Gaebel W (Hrsg.) Evidenzbasierte Suchtmedizin. Behandlungsleitlinie Substanzbezogene Störungen. Deutscher Ärzteverlag, Köln, S. 91–142
Bölcskei PL (2004) Tabakentwöhnung: Kritische Bestandsaufnahme und Chancen für die Zukunft. Pneumologie 58:137–139
Britton J (Hrsg.) (2004) ABC of Smoking cessation. BMJ Books, Blackwell, Oxford
Cahill K, Stead LF, Lancaster T (2007) Nicotine receptor partial agonists for smoking cassation. Cochrane Database of Systematic Reviews Issue 1. Wiley, Chichester
Cokkinides V et al. (2006) Progress and Opportunities in Tobacco Control. CA Cancer J Clin 56:135–142
Cornuz J, Humair JP, Zellweger JP (2004) Tabakentwöhnung 1. Teil: Wie es geht und was es bringt. Schweiz Med Forum 4:764–770
Cornuz J, Humair JP, Zellweger JP (2004) Tabakentwöhnung 2. Teil: Empfehlungen für die tägliche Praxis. Schweiz Med Forum 4:792–805
Deutsches Krebsforschungszentrum (Hrsg.) (2003) Passivrauchende Kinder in Deutschland — Frühe Schädigungen für ein ganzes Leben. DKFZ, Heidelberg
Deutsches Krebsforschungszentrum (Hrsg.) (2003) Tabaksteuererhöhungen — Fakten und Argumente. DKFZ, Heidelberg, 2003
Deutsches Krebsforschungszentrum (Hrsg.) (2005) Passivrauchen — ein unterschätztes Gesundheitsrisiko. DKFZ, Heidelberg, 2005
Fiore MC et al. (2000) Treating Tobacco Use and Dependence. Clinical Practice Guideline, U.S. Department of Health and Human Services, Washington DC
Fletcher C, Peto R (1977) The natural history of chronic airflow obstruction. Brit Med J 1:1645–1648
Gervais A et al. (2006) Milestones in the natural course of onset of cigarette use among adolescents. CMAJ 175(3):255 ff
Gonzales D et al. (2006) Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partila Agonist, vs Substained-Release Bupropion and Placebo for Smoking Cessation. JAMA 296(1):47–55
Henley SJ et al. (2007) Tabacco-related disease mortality among men who switched from cigarettes to spit tabacco. Tabacco-Control 16(1):22–8
Hering T, Bölcskei PL (2002) Raucher in der Praxis entwöhnen. Ein neues Programm ist in über 50% erfolgreich. MMW-Fortschr Med 18:50–51
Hughes JR, Stead LF, Langester T (2007) Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews, Issue 1, Wiley, Chichester
Lancaster T, Stead L, Cahill K (2008) An update on therapeutics for tobacco dependence. Expert opinion on pharmacotherapy 9:15–22
LeSage MG, Keyler DE, Pentel PR (2006) Current status of immunologic approaches to treating tobacco dependence: vaccines and nicotine-specific antibodies. AAPS J 8(1):E65–75
Lob-Corzilius T (2006) Gesundheitsgefahren durch Tabakrauchbelastung von Kindern. Nicorette Science 3:2–4
Maurer P, Bachmann MF (2007) Vaccination against nicotine: an emerging therapy for tobacco dependence. Expert opinion on investigational drugs 16:1775–1783
Miller WR & Rollnick S (2004) Motivierende Gesprächsführung. Lambertus: Freiburg
National Institute for Health and Clinical Excellence (NHS) (2002) Smoking cessation — bupropion and nicotine replacement therapy. Guidance type: Technology Appraisal TA39
Neubauer S et al. (2006) Mortality, morbidity and costs attributable to smoking in Germany: update and a 10-year comparison. Tobacco Control 15:464–471
ÖGAM (2007) Konsensus Statement: Raucherentwöhnung in der allgemeinmedizinischen Praxis. 2. erw. Aufl. Intern Z ärztl Fortb 3
Österreichische Gesellschaft für Pneumologie (ÖGP) (2005) Standards der Raucherentwöhnung. Konsensus der ÖGP. Wiener Klinische Wochenschrift (Suppl.2) 117:1–18
Prochaska JO, DiClemente CC, Norcross JC (1992) In search how people change. Applications to addictive behaviors. American Psychologist 47(9):1102–1114
Raupach T, Nowak D, Hering T, Batra A, Andreas S (2007) Rauchen und pneumologische Erkrankungen, positive Effekte der Tabakentwöhnung. Pneumologie 61:11–14
Silagy C, Lancaster T, Stead LF, Mant D, Fowler G (2005) Nicotine replacement therapy for smoking cessation (Review). Cochrane Library Issue 4, Wiley, Chichester
Stapleton JA, Watson L, Spirling LI, Smith R, Milbrandt A, Ratcliffe M, Sutherland G (2008) Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness. Addiction 103:146–154
Statistisches Bundesamt (Hrsg.) (2006) Leben in Deutschland. Haushalte, Familien und Gesundheit — Ergebnisse des Mikrozensus 2005. Statistisches Bundesamt, Wiesbaden
Stead LF, Lancaster T (2005 ) Group behaviour therapy programmes for smoking cessation. Cochrane Database of Systematic Reviews: Reviews, Issue 2, Wiley, Chichester
Stead LF, Lancaster T (2007) Interventions to reduce harm from continued tobacco use. Cochrane Database of Systematic Reviews, Issue 4, Wiley, Chichester
Tashkin D, Kanne R, Bailey W et al. (2001) Smoking cessation in patients with chronic obstructive pulmonary disease: a double blind placebo-controlled randomised trial. Lancet 357:1571–1575
Thürauf N (2005) Der Schalter zur Sucht: Neue Einblicke in die Tabakabhängigkeit. Nicorette Science 3:2–4
Tverdal A, Bjartveit K (2006). Health consequences of reduced daily cigarette consumption. Tobacco Control 15:472–480
Wennike P, Danielsson T, Landfeldt B, Westin A, Tonnesen P (2003) Smoking reduction promotes smoking cessation: results from a double blind, randomized, placebo-controlled trial of nicotine gum with 2-year follow-up. Addiction 98:1395–1402
West R, Sohal T (2006) »Catastrophic« pathways to smoking cessation: findings from national survey. BMJ 332:458–460
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Bölcskei, P.L. et al. (2008). Spezielle Therapieformen. In: Matthys, H., Seeger, W. (eds) Klinische Pneumologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-37692-7_15
Download citation
DOI: https://doi.org/10.1007/978-3-540-37692-7_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-37682-8
Online ISBN: 978-3-540-37692-7
eBook Packages: Medicine (German Language)